Navigation Links
Exenatide (Byetta) has rapid, powerful anti-inflammatory effect, UB study shows
Date:11/2/2011

BUFFALO, N.Y. -- Exenatide, a drug commonly prescribed to help patients with type 2 diabetes improve blood sugar control, also has a powerful and rapid anti-inflammatory effect, a University at Buffalo study has shown.

The study of the drug, marketed under the trade name Byetta, was published recently in the Journal of Clinical Endocrinology and Metabolism.

"Our most important finding was this rapid, anti-inflammatory effect, which may lead to the inhibition of atherosclerosis, the major cause of heart attacks, strokes and gangrene in diabetics," says Paresh Dandona, MD, UB Distinguished Professor in the Department of Medicine, UB School of Medicine and Biomedical Sciences, and senior author.

It was especially noteworthy that this anti-inflammatory effect occurred independently of weight loss over the 12-week study period, he adds.

"The fact that the drug caused this dramatic and comprehensive anti-inflammatory effect independent of weight loss shows that it is a primary action of the drug and is not dependent upon weight loss," says Ajay Chaudhuri, MD, associate professor of medicine at UB and lead author.

He explains that, since obesity is an inflammatory state and adipose tissue contributes to inflammation, weight loss on its own can lead to an anti-inflammatory effect.

"Even more importantly, a short-lived anti-inflammatory effect was observed within two hours following a single injection of 5 micrograms of the drug," Chaudhuri continues. "This coincides with the peak concentration of the drug after the injection. Such a rapid and dramatic effect is rare."

"Apart from corticosteroids, which are known anti-inflammatory drugs, and insulin, no other drug demonstrates such a powerful and rapid anti-inflammatory effect," adds Dandona.

As a result, he and his colleagues at UB plan to study how exenatide might be used in acute inflammatory settings in the intensive care unit or following heart attack
'/>"/>

Contact: Ellen Goldbaum
goldbaum@buffalo.edu
716-645-4605
University at Buffalo
Source:Eurekalert

Page: 1 2

Related medicine news :

1. JAK inhibitor provides rapid, durable relief for myelofibrosis patients
2. Improved device provides more rapid, comprehensive analysis of circulating tumor cells
3. MRIs could become powerful tools for monitoring cholesteral therapy
4. Unconventional hunt for new cancer targets leads to a powerful drug candidate for leukemia
5. UBC researchers create more powerful lab-on-a-chip for genetic analysis
6. New Canadian blood pressure education program a powerful tool in fight to reduce stroke
7. Dietary inorganic nitrate may reduce heart dysfunction caused by powerful anti-cancer drug
8. Powerful Women as Likely to Cheat as Men, Study Finds
9. Research Warns of Overuse of Powerful Class of Antibiotics
10. New method powerfully boosts efficiency of RNA interference (RNAi) in shutting down genes
11. Scripps Research scientists develop powerful new methodology for stabilizing proteins
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... The U.S. Pharmacopeial Convention is pleased to ... Pharmacy Services at North Carolina State’s College of Veterinary ... Beal Award for Distinguished Volunteer Service—the organization’s highest award. ... contributions of volunteer experts to direct its work to ...
(Date:1/22/2015)... January 22, 2015 Gabe’s Chemo Duck Program is ... the first app ever created for kids with cancer. The Chemo ... and devices, is filled with enjoyable games to help children of ... The free app helps to keep kids entertained, educated and at ...
(Date:1/22/2015)... Blue Cross and Blue Shield of Minnesota ... it means to “Live Fearless.” , The “Faces ... their stories about how they or someone they know has ... living in the moment. By telling these types of stories ...
(Date:1/22/2015)... New York (PRWEB) January 22, 2015 ... after Fresenius Medical Care recalled its GranuFlo and NaturaLyte ... multidistrict litigation underway in U.S. District Court, District of ... dated January 20th, the Court has remanded a case ...
(Date:1/22/2015)... (PRWEB) January 22, 2015 A ... Sports Medicine flagship journal Medicine & Science in ... before exercise may help reduce gastrointestinal (GI) problems ... , Participants in the double-blind, placebo-controlled study ...
Breaking Medicine News(10 mins):Health News:Gigi Davidson, Pioneer in Veterinary Pharmacy and Leader in Pharmacy Compounding, honored with USP’s Beal Award for Dedication to Public Health 2Health News:Gigi Davidson, Pioneer in Veterinary Pharmacy and Leader in Pharmacy Compounding, honored with USP’s Beal Award for Dedication to Public Health 3Health News:Gigi Davidson, Pioneer in Veterinary Pharmacy and Leader in Pharmacy Compounding, honored with USP’s Beal Award for Dedication to Public Health 4Health News:Chemo Duck Launches First App Ever Created for Kids with Cancer 2Health News:Chemo Duck Launches First App Ever Created for Kids with Cancer 3Health News:Blue Cross and Blue Shield of Minnesota to Showcase “Faces of Fearless” 2Health News:Court Overseeing Federal GranuFlo Lawsuits Remands Louisiana Claim Back to State Court, Bernstein Liebhard LLP Reports 2Health News:Court Overseeing Federal GranuFlo Lawsuits Remands Louisiana Claim Back to State Court, Bernstein Liebhard LLP Reports 3Health News:Court Overseeing Federal GranuFlo Lawsuits Remands Louisiana Claim Back to State Court, Bernstein Liebhard LLP Reports 4Health News:Study Shows Kyowa Hakko’s L-Citrulline May Help Reduce Gastrointestinal Injury During Strenuous Exercise 2Health News:Study Shows Kyowa Hakko’s L-Citrulline May Help Reduce Gastrointestinal Injury During Strenuous Exercise 3
... study found that patients with low-grade gliomas survived ... remove the entire tumor. If safely removing the ... longer when surgery was followed by radiation therapy. ... publication in Neuro-Oncology ( http://neuro-oncology.dukejournals.org/cgi/content/abstract/15228517-2008-102v1 ). ...
... Surgeons (ACS) today recognized the Institute of Medicine (IOM) for ... on December 2, 2008, by the IOM Committee on Optimizing ... Patient Safety. , , ... further reductions in the mandated 80-hour work week (averaged over ...
... Aurora Health Care,s Women,s Pavilion,( http://www.aurorahealthcare.org ) and Hair ... a new kind of think pink initiative for breast,cancer; pink ... the month of October, pink hair extensions were being sold ... and at Hair and Body,Solutions Salon and Spa in New ...
... Laboratories, Inc. (NYSE: FRX ) today announced that ... TRC Capital Corporation (TRC) of Toronto, Canada, a private investment ... tender offer to purchase up to 3.0 million outstanding shares ... per cent of its outstanding shares. The offer price ...
... device used extensively in Combat Support Hospitals to treat wounded,soldiers, civilians, ... life of an Omaha, NE Police Officer. , ... traffic stop. One of the bullets,hit him in the abdomen and ... "Injury to this area is often lethal... ...
... MOUNTAIN VIEW, Calif., Dec. 3 MAP,Pharmaceuticals, Inc. (Nasdaq: ... will,participate in a panel discussion titled "Adapting Specialty Pharma ... Healthcare Conference on,Wednesday, December 10, 2008, at 10:00 am ... A live webcast of the panel ...
Cached Medicine News:Health News:Mayo Clinic identifies best treatments for long-term survival in brain tumor patients 2Health News:American College of Surgeons Comments on Institute of Medicine Report on Resident Duty Hours 2Health News:Forest Laboratories Responds To Unsolicited Mini-Tender Offer 2Health News:Forest Laboratories Responds To Unsolicited Mini-Tender Offer 3Health News:Belmont(R) Rapid Infuser Helps Save Officer's Life 2
(Date:1/23/2015)... 2015  Lixte Biotechnology Holdings, Inc. (OTCQB: LIXT), announced that the ... Lixte,s lead compound, LB‑100, is being conducted, has been expanded ... Kovach , M.D., the founder and President of Lixte, said ... a single site. Accrual of patients, however, was slower than ...
(Date:1/23/2015)... , Jan. 23, 2015  CytoSorbents Corporation (NASDAQ ... its CytoSorb® extracorporeal cytokine adsorber to reduce deadly ... the receipt of $385,642, net of transaction costs, ... the Technology Business Tax Certificate Transfer Program sponsored ...
(Date:1/23/2015)... BOSTON , January 23, 2015 Heptares ... is delighted to announce that the Malcolm Campbell ... Congreve (Vice President of Chemistry), Fiona Marshall ... (Chief Executive Officer and co-founder) for the seminal contributions to ...
Breaking Medicine Technology:Lixte Biotechnology Holdings Announces Expansion Of Clinical Sites For Its Phase I Trial Of Its Lead Anti-Cancer Compound, LB-100 2Lixte Biotechnology Holdings Announces Expansion Of Clinical Sites For Its Phase I Trial Of Its Lead Anti-Cancer Compound, LB-100 3CytoSorbents Receives $385,000 in Non-Dilutive Funding from the New Jersey Technology Business Tax Certificate Transfer Program 2CytoSorbents Receives $385,000 in Non-Dilutive Funding from the New Jersey Technology Business Tax Certificate Transfer Program 3Heptares Scientists to Receive the Malcolm Campbell Memorial Prize for 2015 in Recognition of Their Outstanding Contribution to GPCR Drug Discovery 2Heptares Scientists to Receive the Malcolm Campbell Memorial Prize for 2015 in Recognition of Their Outstanding Contribution to GPCR Drug Discovery 3Heptares Scientists to Receive the Malcolm Campbell Memorial Prize for 2015 in Recognition of Their Outstanding Contribution to GPCR Drug Discovery 4
... 2007 - OXiGENE, Inc.,(NASDAQ: OXGN, XSSE: OXGN), a ... and eye,diseases, announced today the publication of two ... afternoon at the,Annual Meeting of the American Society ... abstract reports for the first time full data ...
... Presented at Annual Meeting of the American Society ... June 4, 2007 -- SciClone Pharmaceuticals,Inc. (Nasdaq:SCLN) and ... thymalfasin (ZADAXIN(r), thymosin,alpha 1) achieved its primary endpoint ... with stage IV malignant melanoma, the,most advanced form ...
Cached Medicine Technology:OXiGENE Abstracts Published in ASCO Program 2OXiGENE Abstracts Published in ASCO Program 3OXiGENE Abstracts Published in ASCO Program 4
... Designed and manufactured specifically ... MultiWash II delivers the ... demand. The MultiWash II ... dependable accuracy, while providing ...
... the determination of A1c is also designed to ... is a fully automated analyzer including primary tube ... in safety and positive identification. The analysis methodology ... be interference-free and to produce the lowest CV's ...
Micromat II Hemoglobin A1c instrument is an easy-to-use, accurate and precise instrument with an requirement of only 10 L of capillary or venous sample....
... Cascade M-4 is a manual hemostasis ... routine clotting assays - PTs, aPTTs, ... for easy, inexpensive, low-volume testing, this ... big on features, offering time and ...
Medicine Products: